Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-03 5:28 pm Purchase |
2024-09-14 | 13G | MAIA Biotechnology, Inc. MAIA |
FGMK Business Holdings, LLC | 2,889,561 9.990% |
2,889,561 (New Position) |
Filing History |
| 2025-02-14 5:27 pm Purchase |
2023-12-31 | 13G | MAIA Biotechnology, Inc. MAIA |
Sergei M. Gryaznov | 1,140,115 4.080% |
233,622 (+25.77%) |
Filing History |
| 2024-10-25 6:16 pm Purchase |
2023-04-28 | 13D | MAIA Biotechnology, Inc. MAIA |
Smith Stan | 1,547,933 6.320% |
899,639 (+138.77%) |
Filing History |
| 2024-10-25 5:12 pm Purchase |
2024-03-14 | 13D | MAIA Biotechnology, Inc. MAIA |
Louie Ngar Yee | 1,585,456 6.500% |
520,012 (+48.81%) |
Filing History |
| 2024-10-25 5:10 pm Purchase |
2024-10-25 | 13D | MAIA Biotechnology, Inc. MAIA |
Vitoc Vlad | 3,517,350 13.290% |
371,147 (+11.80%) |
Filing History |
| 2023-02-14 12:00 pm Purchase |
2022-12-31 | 13G | MAIA Biotechnology, Inc. MAIA |
Louie Ngar Yee | 1,065,444 9.590% |
1,065,444 (New Position) |
Filing History |
| 2023-02-14 11:37 am Purchase |
2022-12-31 | 13G | MAIA Biotechnology, Inc. MAIA |
Sergei M. Gryaznov | 906,493 7.660% |
906,493 (New Position) |
Filing History |
| 2023-02-14 11:35 am Purchase |
2022-12-31 | 13G | MAIA Biotechnology, Inc. MAIA |
Vitoc Vlad | 3,146,203 23.980% |
3,146,203 (New Position) |
Filing History |
| 2022-08-09 6:24 pm Purchase |
2022-08-01 | 13D | MAIA Biotechnology, Inc. MAIA |
Smith Stan | 648,294 6.000% |
648,294 (New Position) |
Filing History |